Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 956

Related Citations for PubMed (Select 9030781)

1.

Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.

Meijer L, Borgne A, Mulner O, Chong JP, Blow JJ, Inagaki N, Inagaki M, Delcros JG, Moulinoux JP.

Eur J Biochem. 1997 Jan 15;243(1-2):527-36.

2.

Inhibition of cyclin-dependent kinases by purine analogues.

Veselý J, Havlicek L, Strnad M, Blow JJ, Donella-Deana A, Pinna L, Letham DS, Kato J, Detivaud L, Leclerc S, et al.

Eur J Biochem. 1994 Sep 1;224(2):771-86.

3.

Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine.

De Azevedo WF, Leclerc S, Meijer L, Havlicek L, Strnad M, Kim SH.

Eur J Biochem. 1997 Jan 15;243(1-2):518-26.

4.

Cellular effects of olomoucine, an inhibitor of cyclin-dependent kinases.

Abraham RT, Acquarone M, Andersen A, Asensi A, Bellé R, Berger F, Bergounioux C, Brunn G, Buquet-Fagot C, Fagot D, et al.

Biol Cell. 1995;83(2-3):105-20.

PMID:
7549905
5.

Synthesis and in vitro evaluation of novel 2,6,9-trisubstituted purines acting as cyclin-dependent kinase inhibitors.

Legraverend M, Ludwig O, Bisagni E, Leclerc S, Meijer L, Giocanti N, Sadri R, Favaudon V.

Bioorg Med Chem. 1999 Jul;7(7):1281-93.

PMID:
10465404
6.

The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity.

Alessi F, Quarta S, Savio M, Riva F, Rossi L, Stivala LA, Scovassi AI, Meijer L, Prosperi E.

Exp Cell Res. 1998 Nov 25;245(1):8-18.

PMID:
9828096
7.

Cyclin-dependent kinase inhibitors block proliferation of human gastric cancer cells.

Iseki H, Ko TC, Xue XY, Seapan A, Hellmich MR, Townsend CM Jr.

Surgery. 1997 Aug;122(2):187-94; discussion 194-5.

PMID:
9288122
8.

Adenovirus-mediated E2F-1 gene transfer induces an apoptotic response in human gastric carcinoma cells that is enhanced by cyclin dependent kinase inhibitors.

Atienza C Jr, Elliott MJ, Dong YB, Yang HL, Stilwell A, Liu TJ, McMasters KM.

Int J Mol Med. 2000 Jul;6(1):55-63.

PMID:
10851267
11.

ERK pathway mediates the activation of Cdk2 in IGF-1-induced proliferation of human osteosarcoma MG-63 cells.

Zhang W, Lee JC, Kumar S, Gowen M.

J Bone Miner Res. 1999 Apr;14(4):528-35.

PMID:
10234573
12.

Differential effects of 6-DMAP, olomoucine and roscovitine on Xenopus oocytes and eggs.

Flament S, Bodart JF, Bertout M, Browaeys E, Rousseau A, Vilain JP.

Zygote. 2000 Feb;8(1):3-14.

PMID:
10840869
13.
14.

Cdk2 activity is dispensable for the onset of DNA replication during the first mitotic cycles of the sea urchin early embryo.

Moreau JL, Marques F, Barakat A, Schatt P, Lozano JC, Peaucellier G, Picard A, Genevière AM.

Dev Biol. 1998 Aug 15;200(2):182-97.

15.

Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.

Carlson BA, Dubay MM, Sausville EA, Brizuela L, Worland PJ.

Cancer Res. 1996 Jul 1;56(13):2973-8.

16.

A novel strategy for inhibiting growth of human pancreatic cancer cells by blocking cyclin-dependent kinase activity.

Iseki H, Ko TC, Xue XY, Seapan A, Townsend CM Jr.

J Gastrointest Surg. 1998 Jan-Feb;2(1):36-43.

PMID:
9841966
17.

Synthesis and biological activities of C-2, N-9 substituted 6-benzylaminopurine derivatives as cyclin-dependent kinase inhibitor.

Oh CH, Lee SC, Lee KS, Woo ER, Hong CY, Yang BS, Baek DJ, Cho JH.

Arch Pharm (Weinheim). 1999 Jun;332(6):187-90.

PMID:
10399486
18.

Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinase.

Kitagawa M, Okabe T, Ogino H, Matsumoto H, Suzuki-Takahashi I, Kokubo T, Higashi H, Saitoh S, Taya Y, Yasuda H, et al.

Oncogene. 1993 Sep;8(9):2425-32.

PMID:
8395680
19.

Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.

Yin MB, Guo B, Panadero A, Frank C, Wrzosek C, Slocum HK, Rustum YM.

Exp Cell Res. 1999 Feb 25;247(1):189-99.

PMID:
10047461
20.

Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds.

Havlícek L, Hanus J, Veselý J, Leclerc S, Meijer L, Shaw G, Strnad M.

J Med Chem. 1997 Feb 14;40(4):408-12.

PMID:
9046330
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk